Synthesis, anticancer evaluation and docking studies of novel adamantanyl-1, 3, 4-oxadiazol hybrid compounds as Aurora-A kinase inhibitors

11.Sep.2023

​Jaber, A. M., Al-Mahadeen, M. M., Al-Qawasmeh, R. A., & Taha, M. O. (2023). Synthesis, anticancer evaluation and docking studies of novel adamantanyl-1, 3, 4-oxadiazol hybrid compounds as Aurora-A kinase inhibitors. Medicinal Chemistry Research, 1-11.​